Tapewire

Nasdaq · USD

CTXR

Citius Pharmaceuticals, Inc.

Export transactions ↓
Tapewire entity
7778
SEC CIK
0001506251
Parsed reports
102

Last 12 months

Inside the activity.

0 purchase rows · 0 sale rows

Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.
Monthly counts
MonthPurchasesSales
Nov 202500
Dec 202500
Jan 202600
Feb 202600
Mar 202600
Apr 202600
May 202600
Jun 202600
Jul 202600
Aug 202600
Sep 202600
Oct 202600

Latest available

Insider transactions

JSON API
Reset

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction dateOwner / reported roleActivity / securityShares / unitsReported priceReported valueDetails
October 08, 2019 Filed Oct 10, 2019 20:06 UTC
Bartushak JaimeChief Financial Officer
GrantStock Option (Right to Purchase Common Stock) · Derivative 100,000 $0.00 Strike: $0.67 $0.00
Disclosure

SEC source: 0001213900-19-020111 · ownership.xml · derivative · entry 2

Bartushak Jaime · CIK 0001725077 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 100,000

Underlying: Common Stock · 100,000 shares

Expires 2029-10-08

F1 · security: The options were granted on October 8, 2019. The options will vest 1/3 on each of the one-year, two-year and three-year anniversary of the Vesting Commencement Date, provided that the Optionee provides Continuous Service to the Company on each such vesting date.

F1 · derivative.exercise_date: The options were granted on October 8, 2019. The options will vest 1/3 on each of the one-year, two-year and three-year anniversary of the Vesting Commencement Date, provided that the Optionee provides Continuous Service to the Company on each such vesting date.

Read SEC document
September 27, 2019 Filed Sep 27, 2019 16:16 UTC
Mazur Leonard LDirector · Executive Chairman · 10% owner
PurchaseWarrant to Purchase Common Stock · Derivative 2,234,700 Not disclosed Strike: $0.77 Not disclosed
Disclosure

SEC source: 0001213900-19-019180 · ownership.xml · derivative · entry 20

Mazur Leonard L · CIK 0001463414 · Director · Executive Chairman · 10% owner

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 2,234,700

Underlying: Common Stock · 2,234,700 shares

Expires 2024-09-27

F2 · security: The warrant is fully vested and exercisable immediately.

F4 · price: The purchase price of the warrants was included in the purchase price of the common stock reported in Table I.

F2 · derivative.exercise_date: The warrant is fully vested and exercisable immediately.

Read SEC document
September 27, 2019 Filed Sep 27, 2019 16:16 UTC
Mazur Leonard LDirector · Executive Chairman · 10% owner
PurchaseCommon Stock 2,234,700 $0.90 $2,000,279.97
Disclosure

SEC source: 0001213900-19-019180 · ownership.xml · nonDerivative · entry 1

Mazur Leonard L · CIK 0001463414 · Director · Executive Chairman · 10% owner

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 10,255,343

Read SEC document
September 27, 2019 Filed Sep 27, 2019 16:15 UTC
HOLUBIAK MYRON ZDirector · President and CEO · 10% owner
PurchaseWarrant to Purchase Common Stock · Derivative 558,597 Not disclosed Strike: $0.77 Not disclosed
Disclosure

SEC source: 0001213900-19-019177 · ownership.xml · derivative · entry 8

HOLUBIAK MYRON Z · CIK 0001199080 · Director · President and CEO · 10% owner

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 558,597

Underlying: Common Stock · 558,597 shares

Expires 2024-09-27

F1 · security: The warrant is fully vested and exercisable immediately.

F2 · price: The purchase price of the warrants was included in the purchase price of the common stock reported in Table I.

F1 · derivative.exercise_date: The warrant is fully vested and exercisable immediately.

Read SEC document
September 27, 2019 Filed Sep 27, 2019 16:15 UTC
HOLUBIAK MYRON ZDirector · President and CEO · 10% owner
PurchaseCommon Stock 558,597 $0.90 $500,000.17
Disclosure

SEC source: 0001213900-19-019177 · ownership.xml · nonDerivative · entry 1

HOLUBIAK MYRON Z · CIK 0001199080 · Director · President and CEO · 10% owner

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,992,243

Read SEC document
April 03, 2019 Filed Apr 5, 2019 16:06 UTC
Mazur Leonard LDirector · Executive Chairman · 10% owner
PurchaseWarrant to Purchase Common Stock · Derivative 1,165,048 Not disclosed Strike: $1.42 Not disclosed
Disclosure

SEC source: 0001213900-19-005844 · ownership.xml · derivative · entry 19

Mazur Leonard L · CIK 0001463414 · Director · Executive Chairman · 10% owner

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,615,048

Underlying: Common Stock · 1,165,048 shares

Expires 2021-04-05

F2 · security: The warrant is fully vested and exercisable immediately.

F4 · price: The purchase price of the warrants was included in the purchase price of the common stock reported in Table I.

F2 · derivative.exercise_date: The warrant is fully vested and exercisable immediately.

Read SEC document
April 03, 2019 Filed Apr 5, 2019 16:06 UTC
Mazur Leonard LDirector · Executive Chairman · 10% owner
PurchaseCommon Stock 1,165,048 $1.55 $1,799,999.16
Disclosure

SEC source: 0001213900-19-005844 · ownership.xml · nonDerivative · entry 1

Mazur Leonard L · CIK 0001463414 · Director · Executive Chairman · 10% owner

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 8,020,643

Read SEC document
April 03, 2019 Filed Apr 5, 2019 16:06 UTC
HOLUBIAK MYRON ZDirector · President and CEO · 10% owner
PurchaseWarrant to Purchase Common Stock · Derivative 129,450 Not disclosed Strike: $1.42 Not disclosed
Disclosure

SEC source: 0001213900-19-005843 · ownership.xml · derivative · entry 7

HOLUBIAK MYRON Z · CIK 0001199080 · Director · President and CEO · 10% owner

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 129,450

Underlying: Common Stock · 129,450 shares

Expires 2021-04-05

F1 · security: The warrant is fully vested and exercisable immediately.

F2 · price: The purchase price of the warrants was included in the purchase price of the common stock reported in Table I.

F1 · derivative.exercise_date: The warrant is fully vested and exercisable immediately.

Read SEC document
April 03, 2019 Filed Apr 5, 2019 16:06 UTC
HOLUBIAK MYRON ZDirector · President and CEO · 10% owner
PurchaseCommon Stock 129,450 $1.55 $200,000.25
Disclosure

SEC source: 0001213900-19-005843 · ownership.xml · nonDerivative · entry 1

HOLUBIAK MYRON Z · CIK 0001199080 · Director · President and CEO · 10% owner

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,433,646

Read SEC document
September 04, 2018 Filed Sep 6, 2018 16:18 UTC
Webb CarolDirector
GrantOptions to Purchase Common Stock · Derivative 15,000 $0.00 Strike: $1.62 $0.00
Disclosure

SEC source: 0001213900-18-012204 · ownership.xml · derivative · entry 1

Webb Carol · CIK 0001671111 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 15,000

Underlying: Common Stock · 15,000 shares

Expires 2028-09-04

F1 · security: The options vest in full on the first anniversary of the vesting commencement date, September 4, 2019.

F1 · derivative.exercise_date: The options vest in full on the first anniversary of the vesting commencement date, September 4, 2019.

Read SEC document
September 04, 2018 Filed Sep 6, 2018 16:12 UTC
Kane WilliamDirector
GrantOptions to Purchase Common Stock · Derivative 15,000 $0.00 Strike: $1.62 $0.00
Disclosure

SEC source: 0001213900-18-012197 · ownership.xml · derivative · entry 1

Kane William · CIK 0001671585 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 15,000

Underlying: Common Stock · 15,000 shares

Expires 2028-09-04

F1 · security: The options vest in full on the first anniversary of the vesting commencement date, September 4, 2019.

F1 · derivative.exercise_date: The options vest in full on the first anniversary of the vesting commencement date, September 4, 2019.

Read SEC document
September 04, 2018 Filed Sep 6, 2018 16:14 UTC
Mazur Leonard LDirector · Executive Chairman · 10% owner
GrantOptions to Purchase Common Stock · Derivative 150,000 $0.00 Strike: $1.62 $0.00
Disclosure

SEC source: 0001213900-18-012199 · ownership.xml · derivative · entry 18

Mazur Leonard L · CIK 0001463414 · Director · Executive Chairman · 10% owner

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 150,000

Underlying: Common Stock · 150,000 shares

Expires 2028-09-04

F5 · security: One-third of the shares of the Company's common stock underlying the grant vest on each of the one-year, two-year and three-year anniversary of the vesting commencement date, September 4, 2018, provided that the Reporting Person provides continuous services to the Company as of each such vesting date.

F5 · derivative.exercise_date: One-third of the shares of the Company's common stock underlying the grant vest on each of the one-year, two-year and three-year anniversary of the vesting commencement date, September 4, 2018, provided that the Reporting Person provides continuous services to the Company as of each such vesting date.

Read SEC document
September 04, 2018 Filed Sep 6, 2018 16:16 UTC
SAFIR HOWARDDirector
GrantOptions to Purchase Common Stock · Derivative 15,000 $0.00 Strike: $1.62 $0.00
Disclosure

SEC source: 0001213900-18-012201 · ownership.xml · derivative · entry 1

SAFIR HOWARD · CIK 0001221559 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 15,000

Underlying: Common Stock · 15,000 shares

Expires 2028-09-04

F1 · security: The options vest in full on the first anniversary of the vesting commencement date, September 4, 2019.

F1 · derivative.exercise_date: The options vest in full on the first anniversary of the vesting commencement date, September 4, 2019.

Read SEC document
September 04, 2018 Filed Sep 6, 2018 16:10 UTC
HOLUBIAK MYRON ZDirector · President and CEO · 10% owner
GrantOptions to Purchase Common Stock · Derivative 150,000 $0.00 Strike: $1.62 $0.00
Disclosure

SEC source: 0001213900-18-012192 · ownership.xml · derivative · entry 6

HOLUBIAK MYRON Z · CIK 0001199080 · Director · President and CEO · 10% owner

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 150,000

Underlying: Common Stock · 150,000 shares

Expires 2028-09-04

F5 · security: One-third of the shares of the Company's common stock underlying the grant vest on each of the one-year, two-year and three-year anniversary of the vesting commencement date, September 4, 2018, provided that the Reporting Person provides continuous services to the Company as of each such vesting date.

F5 · derivative.exercise_date: One-third of the shares of the Company's common stock underlying the grant vest on each of the one-year, two-year and three-year anniversary of the vesting commencement date, September 4, 2018, provided that the Reporting Person provides continuous services to the Company as of each such vesting date.

Read SEC document
September 04, 2018 Filed Sep 6, 2018 20:11 UTC GrantOptions to Purchase Common Stock · Derivative 15,000 $0.00 Strike: $1.62 $0.00
Disclosure

SEC source: 0001213900-18-012195 · ownership.xml · derivative · entry 1

Holuka Eugene Myron · CIK 0001678292 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 15,000

Underlying: Common Stock · 15,000 shares

Expires 2028-09-04

F1 · derivative.exercise_date: The options vest in full on the first anniversary of the vesting commencement date, September 4, 2019.

Read SEC document
September 04, 2018 Filed Sep 6, 2018 20:08 UTC GrantOptions to Purchase Common Stock · Derivative 15,000 $0.00 Strike: $1.62 $0.00
Disclosure

SEC source: 0001213900-18-012190 · ownership.xml · derivative · entry 1

Dutia Suren G · CIK 0001514063 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 15,000

Underlying: Common Stock · 15,000 shares

Expires 2028-09-04

F1 · security: The options vest in full on the first anniversary of the vesting commencement date, September 4, 2019.

F1 · derivative.exercise_date: The options vest in full on the first anniversary of the vesting commencement date, September 4, 2019.

Read SEC document
September 04, 2018 Filed Sep 6, 2018 20:06 UTC
Bartushak JaimeChief Financial Officer
GrantStock Option (Right to Purchase Common Stock) · Derivative 70,000 $0.00 Strike: $1.62 $0.00
Disclosure

SEC source: 0001213900-18-012187 · ownership.xml · derivative · entry 2

Bartushak Jaime · CIK 0001725077 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 70,000

Underlying: Common Stock · 70,000 shares

Expires 2028-09-04

F1 · security: One-third of the shares of the Company's common stock underlying the grant vest on each of the one-year, two-year and three-year anniversary of the vesting commencement date, September 4, 2018, provided that the Reporting Person provides continuous services to the Company as of each such vesting date.

F1 · derivative.exercise_date: One-third of the shares of the Company's common stock underlying the grant vest on each of the one-year, two-year and three-year anniversary of the vesting commencement date, September 4, 2018, provided that the Reporting Person provides continuous services to the Company as of each such vesting date.

Read SEC document
August 13, 2018 Filed Aug 15, 2018 17:07 UTC
Mazur Leonard LDirector · Executive Chairman · 10% owner
GrantWarrant to Purchase Common Stock · Derivative 3,137,255 Not disclosed Strike: $1.15 Not disclosed
Disclosure

SEC source: 0001213900-18-011213 · ownership.xml · derivative · entry 17

Mazur Leonard L · CIK 0001463414 · Director · Executive Chairman · 10% owner

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 3,137,255

Underlying: Common Stock · 3,137,255 shares

Expires 2023-08-14

F2 · security: The warrant is fully vested and exercisable immediately.

F4 · price: The purchase price of the warrants was included in the purchase price of the common stock reported in Table I.

F2 · derivative.exercise_date: The warrant is fully vested and exercisable immediately.

Read SEC document
August 13, 2018 Filed Aug 15, 2018 17:07 UTC
Mazur Leonard LDirector · Executive Chairman · 10% owner
PurchaseCommon Stock 3,137,255 $1.28 $4,000,000.13
Disclosure

SEC source: 0001213900-18-011213 · ownership.xml · nonDerivative · entry 1

Mazur Leonard L · CIK 0001463414 · Director · Executive Chairman · 10% owner

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 6,855,595

Read SEC document
August 13, 2018 Filed Aug 15, 2018 17:06 UTC
HOLUBIAK MYRON ZDirector · President and CEO · 10% owner
GrantWarrant to Purchase Common Stock · Derivative 784,314 Not disclosed Strike: $1.15 Not disclosed
Disclosure

SEC source: 0001213900-18-011211 · ownership.xml · derivative · entry 2

HOLUBIAK MYRON Z · CIK 0001199080 · Director · President and CEO · 10% owner

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 784,314

Underlying: Common Stock · 784,314 shares

Expires 2023-08-14

F1 · security: The warrant is fully vested and exercisable immediately.

F2 · price: The purchase price of the warrants was included in the purchase price of the common stock reported in Table I.

F1 · derivative.exercise_date: The warrant is fully vested and exercisable immediately.

Read SEC document
August 13, 2018 Filed Aug 15, 2018 17:06 UTC
HOLUBIAK MYRON ZDirector · President and CEO · 10% owner
PurchaseCommon Stock 784,314 $1.28 $1,000,000.35
Disclosure

SEC source: 0001213900-18-011211 · ownership.xml · nonDerivative · entry 1

HOLUBIAK MYRON Z · CIK 0001199080 · Director · President and CEO · 10% owner

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,304,196

Read SEC document
March 29, 2018 Filed Apr 2, 2018 15:56 UTC
Mazur Leonard LDirector · Executive Chairman · 10% owner
PurchaseWarrant to Purchase Common Stock · Derivative 167,504 Not disclosed Strike: $2.86 Not disclosed
Disclosure

SEC source: 0001213900-18-003856 · f4032918mazur_citiuspharma.xml · derivative · entry 16

Mazur Leonard L · CIK 0001463414 · Director · Executive Chairman · 10% owner

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 167,504

Underlying: Common Stock · 167,504 shares

Expires 2023-09-29

F2 · security: The warrant is fully vested and exercisable immediately.

F6 · price: The purchase price of the warrants was included in the purchase price of the common stock reported in Table I.

F2 · derivative.exercise_date: The warrant is fully vested and exercisable immediately.

Read SEC document
March 29, 2018 Filed Apr 2, 2018 15:56 UTC
Mazur Leonard LDirector · Executive Chairman · 10% owner
PurchaseCommon Stock 167,504 $2.99 $499,999.44
Disclosure

SEC source: 0001213900-18-003856 · f4032918mazur_citiuspharma.xml · nonDerivative · entry 1

Mazur Leonard L · CIK 0001463414 · Director · Executive Chairman · 10% owner

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 3,718,340

Read SEC document
March 28, 2018 Filed Mar 29, 2018 18:00 UTC
HOLUBIAK MYRON ZDirector · President and CEO
PurchaseCommon Stock 2,915 $3.09 $9,007.35
Disclosure

SEC source: 0001213900-18-003691 · f4032818holubiak_citiuspharm.xml · nonDerivative · entry 1

HOLUBIAK MYRON Z · CIK 0001199080 · Director · President and CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 519,882

Read SEC document
December 19, 2017 Filed Jan 8, 2018 16:05 UTC
Mazur Leonard LDirector · Executive Chairman · 10% owner
PurchaseCommon Stock 213,106 $4.69 $999,467.14
Disclosure

SEC source: 0001213900-18-000250 · f4121917mazur_citiuspharma.xml · nonDerivative · entry 1

Mazur Leonard L · CIK 0001463414 · Director · Executive Chairman · 10% owner

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 3,550,836

Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.